A detailed history of Lido Advisors, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Lido Advisors, LLC holds 772 shares of BIO stock, worth $270,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares
772
Previous 748 3.21%
Holding current value
$270,377
Previous $204,000 26.47%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $6,335 - $8,271
24 Added 3.21%
772 $258,000
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $193,415 - $244,765
-721 Reduced 49.08%
748 $204,000
Q1 2024

May 15, 2024

SELL
$304.11 - $351.99 $183,378 - $212,249
-603 Reduced 29.1%
1,469 $508,000
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $226,809 - $307,363
842 Added 68.46%
2,072 $669,000
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $143,952 - $173,700
411 Added 50.18%
1,230 $440,000
Q2 2023

Aug 09, 2023

BUY
$359.49 - $486.4 $294,422 - $398,361
819 New
819 $310,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.63B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.